USING REAL-WORLD EVIDENCE TO SUPPORT REIMBURSEMENT DECISION-MAKING IN CHINA: CURRENT PRACTICES, CHALLENGES AND OPPORTUNITIES

被引：0
|
作者：
Liu, J. [1 ]
Feng, Y. [1 ]
Yang, S. [1 ]
Yin, Z. [1 ]
Xie, Y. [2 ]
机构：
[1] IQVIA, Beijing, Peoples R China
[2] IQVIA, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE451
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [1] Real-world endpoints to support regulatory decision-making
    Christian, Jennifer B.
    Warren, Edward J.
    Cameron, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 427 - 427
  • [2] Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making
    Alnofal, Fatemah A.
    Alrwisan, Adel A.
    Alshammari, Thamir M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1303 - 1306
  • [3] What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward
    Kc, Sarin
    Lin, Lydia Wenxin
    Bayani, Diana Beatriz Samson
    Zemlyanska, Yaroslava
    Adler, Amanda
    Ahn, Jeonghoon
    Chan, Kelvin
    Choiphel, Dechen
    Genuino-Marfori, Anne Julienne
    Kearney, Brendon
    Liu, Yuehua
    Nakamura, Ryota
    Pearce, Fiona
    Prinja, Shankar
    Pwu, Raoh-Fang
    Shafie, Arsul Akmal
    Sui, Binyan
    Suwantika, Auliya
    Tunis, Sean
    Wu, Hui-Min
    Zalcberg, John
    Zhao, Kun
    Isaranuwatchai, Wanrudee
    Teerawattananon, Yot
    Wee, Hwee-Lin
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2023, 12
  • [4] CONTEXT MATTERS - A TAXONOMY OF REAL-WORLD DATA AND EVIDENCE TO SUPPORT HTA DECISION-MAKING
    Murphy, L. A.
    Mestre-Ferrandiz, J.
    Sola-Morales, O.
    de Pouvourville, G.
    Cunningham, D.
    Corry, S.
    Akehurst, R.
    VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [5] KEY CONSIDERATIONS FOR EVALUATING REAL-WORLD EVIDENCE IN SUPPORT OF FDA REGULATORY DECISION-MAKING
    Li, Jie
    INNOVATION IN AGING, 2022, 6 : 193 - 193
  • [6] The application of real-world evidence in drug regulatory decision-making
    Wicherski, Julia
    Haenisch, Britta
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2024, 67 (02) : 255 - 256
  • [7] The Growing Role of Real-World Evidence in Clinical Decision-Making
    Owens, Gary M.
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (08): : 401 - 401
  • [8] Comparison of two assessments of real-world data and real-world evidence for regulatory decision-making
    Yuan, Lily
    Rahman, Motiur
    Concato, John
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
  • [9] Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms
    Burcu, Mehmet
    Dreyer, Nancy A.
    Franklin, Jessica M.
    Blum, Michael D.
    Critchlow, Cathy W.
    Perfetto, Eleanor M.
    Zhou, Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1228 - 1235
  • [10] Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World
    Burns, Leah
    Le Roux, Nadege
    Kalesnik-Orszulak, Robert
    Christian, Jennifer
    Hukkelhoven, Mathias
    Rockhold, Frank
    O'Donnell, John
    CLINICAL THERAPEUTICS, 2022, 44 (03) : 420 - 437
12345